[Alpha 2plasmin-inhibitor . plasmin complex (PIC)--useful diagnostic and prognostic parameter]

Current diagnostic tools for coagulation disorders lack sufficient sensitivity and specificity. Standard scoring systems like the DIC score combine multiple parameters but miss subtle changes in fibrinolytic activity. This diagnostic gap limits early detection of severe coagulopathy. Prior research has shown that fibrinolytic markers can reflect disease progression. However, no single marker has been validated for both diagnosis and prognosis. The need for a more accurate biomarker remains unmet in critical care settings. This uncertainty drives the search for alternative diagnostic indicators. No prior work has resolved the limitations of existing scoring systems.

This study aimed to assess the diagnostic and prognostic value of PIC in patients with coagulofibrinolytic abnormalities. The specific problem is the lack of a reliable biomarker for disseminated intravascular coagulation (DIC). The motivation stems from the limitations of existing diagnostic tools. The researchers tested PIC against the established DIC score. They evaluated 182 samples from 60 patients. The goal was to determine if PIC could improve diagnostic accuracy and predict outcomes. The study focused on sensitivity and specificity comparisons. This approach allows direct comparison with current standards.

The researchers analyzed 182 blood samples from 60 patients with suspected coagulopathy. They measured PIC levels and calculated the DIC score for each sample. The study used standard laboratory techniques for fibrinogen, FDP, and prothrombin time. They compared diagnostic accuracy using chi-square tests. For prognosis, they tracked peak PIC and DIC score values during the clinical course. Non-survivors and survivors were grouped for comparison. Statistical analysis included mean comparisons and mortality rates. This method allowed direct evaluation of PIC's clinical utility.

PIC demonstrated higher sensitivity than the DIC score for diagnosing DIC (78.46% vs 43.08%). However, PIC had lower specificity (32.48% vs 69.23%). Non-survivors had significantly higher peak PIC levels (6.1 ± 9.0 vs 2.2 ± 3.3 µg/ml). Peak DIC scores also differed between groups (4.6 ± 2.4 vs 3.3 ± 2.2 points). Mortality exceeded 90% when PIC was above 4.0 µg/ml. These differences reached statistical significance (p < 0.05). The results suggest PIC reflects disease severity better than the DIC score. The findings support PIC as a more informative biomarker.

The authors suggest that PIC may serve as a more sensitive diagnostic tool for DIC than the standard DIC score. They propose that PIC could better identify patients with severe coagulopathy. The data indicate that PIC levels correlate with mortality risk. The study shows PIC's potential for both diagnosis and prognosis. The results highlight PIC's value in critical care settings. The findings support further clinical validation of PIC. The authors suggest that PIC may improve patient stratification. These conclusions are based on the observed statistical differences.